-
Yes, Omicron is Here but No Need for Panic
Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and Isolation” webpage to allow readers to better understand what to do. The updates have extra charts for readers to better understand when to test and when traveling can be allowed.…
-
OSHA ETS Temporarily Stayed…and Other COVID News
Key Points In today’s Recommendations for Industry, we discuss the stay of the OSHA ETS, the Pfizer antiviral, and a Science vaccine efficacy study. Read more below. On Saturday, a federal appeals court issued a stay of the Biden administration's vaccine mandate for private companies. In the brief order temporarily blocking the new vaccine rules…
-
Case Rates Fluctuating Around the Globe
In today’s Recommendations for Industry, we discuss the fluctuation in case rates. Read more below. At least 5 million people worldwide have died from Covid – though experts believe the total number is undoubtedly far higher. COVID-19 is responsible for more than five million confirmed deaths around the world –a loss that would wipe out…
-
Influenza, COVID-19 Vaccines and Vaccinations
In today’s Recommendations for Industry, we discuss the conversations, news, and status of influenza, COVID-19, and their vaccines and vaccinations. Read more below. Research published through SUNY Geneseo of limiting COVID-19 on college campuses has found that “masking was the most effective non-pharmaceutical way to prevent the spread of COVID-19 on a college campus, followed…
-
Are you Prepared for the OSHA Vaccine/Testing Standards?
In today’s Recommendations for Industry, we discuss how to prepare for the OSHA vaccine and testing standards. Read more below. If you’re interested in how the WHO estimates excess COVID-19 deaths, the WHO has published its methodology here. CNBC discusses that if one is fired for refusing a COVID-19 vaccine, depending on a state’s regulations,…
-
COVID Mitigation Continues with Booster Guidance and Antivirals
In today’s Recommendations for Industry, we discuss COVID post-infection antiviral medication trials that are nearing completion. Read more below. Viruses limited by COVID-19 restrictions may arise again this fall, including “common respiratory viruses” like the common cold! The CDC has released “Who is Eligible for a COVID-19 Booster Shot.” Booster shots are available for anyone…
-
Percent of Vaccinated Can Determine Needed Protections
Key Points In today’s Recommendations for Industry, we discuss how to implicate protections based off your employee’s vaccination status. Read more below. As the Delta variant’s prevalence rises throughout the country and throughout the world (especially in areas with lower vaccination rates), countries are tightening (or re-tightening) restrictions. In fact, India is currently tracking a…